Latest filing: Biocon Ltd - 532523 - Company Statement
ObservedCompany dossier
Biocon
NSE:BIOCON · ISIN INE376G01013
- Close
- ₹431.1 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Biocon
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Mar 2026 · revenue ₹4,516.6 Cr · PAT ₹198.6 Cr.
Exchange XBRLLatest ownership: promoter group 44.68% and public 55.27% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Biocon Ltd - 532523 - Company Statement
BSE · exchange filing
Observed
Source filing Updates - Biocon Limited
NSE · exchange filing
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Biocon Limited
NSE · conference call
Observed
Source filing Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Reported financials
Full financials →31 Mar 2026
- Revenue from operations
- ₹4,516.6 Cr
- Profit after tax
- ₹198.6 Cr
- EPS
- ₹0.79
Observed BSE structured filing · consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 44.68%
- Public
- 55.27%
- Employee trust
- 0.05%
Observed NSE shareholding XBRL